10295520 · Active · incorporated 10 years ago · London
Biotech Biotech & Life Sciences Drug Discovery Series B+
Epsilogen is a clinical-stage biotechnology company developing novel antibody therapeutics for oncology.
See the complete cap table with every shareholder, founder tags, dilution across 21 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.